Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Indraprastha Medical Corporation Ltd has informed BSE regarding the details of Voting results at the 28th Annual General Meeting (AGM) of the Company held on August 30, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 along with Scrutinizer's Report and Proceedings of the Meeting in this regard. Standalone Financial Results, Limited Review Report for June 30, 2016
Indraprastha Medical Corporation Ltd has informed BSE about : 1. Standalone Financial Results for the period ended June 30, 20162. Standalone Limited Review for the period ended June 30, 2016 Closure of Trading Window
Indraprastha Medical Corporation Ltd has informed BSE that Trading Window shall remain closed from August 23, 2016 to September 02, 2016 (both days inclusive) in connection with the forthcoming Board meeting of the Company scheduled to be held on August 30, 2016, for declaration of financial results for the quarter ended June 30, 2016. Board Meeting Intimation for Results
Indraprastha Medical Corporation Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 30, 2016, to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2016. Fixes Book Closure for Dividend & AGM
Indraprastha Medical Corporation Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from August 20, 2016 to August 30, 2016 (both days inclusive) for the purpose of Payment of Dividend & 28th Annual General Meeting (AGM) of the Company to be held on August 30, 2016. Shareholding for the Period Ended June 30, 2016
Indraprastha Medical Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click here Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
Indraprastha Medical Corporation Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Board recommends Dividend
Indraprastha Medical Corporation Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 20, 2016, inter alia, has recommended the payment of dividend @ 18% i.e. (Rs. 1.80 per share) for the financial year 2015-16. Standalone Financial Results, Form A, Auditors Report for March 31, 2016
Indraprastha Medical Corporation Ltd has informed BSE about : 1. Standalone Financial Results for the period ended March 31, 20162. Standalone Form A for the period ended March 31, 20163. Standalone Auditors Report for the period ended March 31, 2016